VENXXIVA™ (tiopronin) Delayed-Release Tablets

Helping you manage life’s complexities.

VENXXIVA is a proven treatment for cystinuria that can help you find relief by reducing the frequency and severity of stone formation.1 VENXXIVA is available in a 300 mg tablet which may reduce the number of pills you need to take daily.

Find out more about VENXXIVA

NOT ACTUAL PATIENT

NOT ACTUAL PATIENT

Product

VENXXIVA works by maintaining low cystine concentration in the urine to prevent stone formation. VENXXIVA is taken alongside high fluid intake, alkali and diet modifications.2

HCP Icon
FDA-approved
Medication Icon
Available in 100 mg and 300 mg doses2
Apple Icon
VENXXIVA (tiopronin) Delayed-Release Tablets must be taken without food2
Learn more about VENXXIVA

Support

VENXXIVA is accompanied by our dedicated support program Cycle Vita™ which can provide you with individualized product support,* including:

Medication Form Icon
Bridge Program
Care Icon
Continuous Product and Process Support
Payment Icon
Financial Assistance
Food Approve Icon
Patient Nutrition Program
Learn more about Cycle Vita

*Some areas of support may not be accessible to all patients. Eligibility criteria may apply to ensure compliance with all applicable federal and state requirements, and benefits may be limited to commercially insured patients only. For more detailed information about eligibility, terms and conditions, please contact the Cycle Vita team at 888-360-8482.

References

  1. Pak et al., 2018. The Journal of Urology. Management of cystine nephrolithiasis with alpha-mercaptopropionylglycine. 136(5):1003-8. DOI: 10.1016/s0022-5347(17)45188-3 [Accessed: September 10 2024].
  2. VENXXIVA (tiopronin) Delayed-Release Tablets. Prescribing Information. Torrent Pharma Inc.